Cargando…
Recurrent oligodendroglioma with changed 1p/19q status
We report a case of oligodendroglioma that had consistent histopathological features as well as a distinct change in 1p/19q status in the second recurrence, after temozolomide chemotherapy and radiotherapy. The first tumor recurrence had oligodendroglial morphology, IDH1 R132H and TERT promoter muta...
Autores principales: | Barresi, Valeria, Mafficini, Andrea, Calicchia, Martina, Piredda, Maria Liliana, Musumeci, Angelo, Ghimenton, Claudio, Scarpa, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546156/ https://www.ncbi.nlm.nih.gov/pubmed/35144313 http://dx.doi.org/10.1111/neup.12789 |
Ejemplares similares
-
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation
por: Barresi, Valeria, et al.
Publicado: (2021) -
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment
por: Barresi, Valeria, et al.
Publicado: (2019) -
Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
por: Barresi, Valeria, et al.
Publicado: (2021) -
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology
por: Ammendola, Serena, et al.
Publicado: (2021) -
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells
por: Barresi, Valeria, et al.
Publicado: (2022)